Save after changing Favorites. Use Share Link when you want the same list on another device.
Your link (Favorites):
All Favorites
#
Name
Description
Category
Type
Source
Website
RES
New approaches for Human/AI collaboration for the workforce of the future (RIA) (Made in Europe and AI, Data and Robotics partnerships)
ec.europa.eu
Expected Outcome:Industrial jobs are transformed through AI-based human-machine interactions (and skills linked to them) which enhance flexibility, in...
Research FundingCash GrantEuropeOpen
AmountExpected EU contribution: 4,000,000 EUR - 6,000,000 EUR
DeadlineSep 2, 2027
Expected Outcome:Industrial jobs are transformed through AI-based human-machine interactions (and skills linked to them) which enhance flexibility, inclusion, well-being, up-skilling, career evolution and knowledge sharing;Increased competitiveness and sustainability of advanced manufacturing industries by means of knowledge formalization and adaptability of the machines to workers and markets based on different cultures. Scope:Innovative AI approaches are poised to revolutionise human-machine collaboration in factories by fostering an environment where technology and human expertise synergistically enhance each other. AI can enhance the value of the companies by capturing and formalising the knowledge which is dispersed and not explicit. This allows companies to really own the knowledge and use it to reduce the onboarding time of new employees and support personnel upskilling to adapt t...
RES
Efficient energy input from renewable sources and energy management in the process industries (IA) (Processes4Planet and Innovative Advanced Materials for the EU partnerships)
ec.europa.eu
Expected Outcome:A significant decarbonisation of processes (measured by the reduction of GHG emissions from the overall system) with broad applicabil...
Research FundingCash GrantEuropeOpen
AmountExpected EU contribution: 7,000,000 EUR - 9,000,000 EUR
DeadlineSep 2, 2027
Expected Outcome:A significant decarbonisation of processes (measured by the reduction of GHG emissions from the overall system) with broad applicability and economic viability.Facilitation of the transition from fossil-based energy inputs for: low/medium thermal energy demands by introducing renewable-based alternatives and heat upgrading. High-temperature processes, by innovative technologies for electrified and hybrid high-temperature processes, high temperature energy storage. Clean energy usage is given a boost through innovative advanced materials, system concepts and technologies for energy integration and energy storage, supporting resilience against energy supply variationsCombination of significant energy savings and integrated management of energy systems and production processes Scope:Most processes in the process industries require significant energy inputs which currently l...
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tiotropiumbromid, in der Darreichungsform Inhalationslösung (Respimat(R)), ATC R03BB04
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineSep 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Timolol und Tafluprost, ATC S01ED70
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineSep 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Paliperidon, in 3-Monats-Depot-Darreichungsformen, ATC N05AX13
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineSep 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Octreotid, ATC H01CB02
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineSep 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Timolol und Brinzolamid, ATC S01ED67
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineSep 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-03
TEN
Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-09
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens
ted.europa.eu
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tiotropiumbromid ausschließlich in der Dafo Lösung zur Inhalation, ATC R03BB04 f. d. Z. 01.11.25 - 31.10.27
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Raltegravir, ATC J05AJ01 für die Zeit 01.11.2025 - 31.10.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Allergenextrakt aus Birkenpollen ausschießlich Dafo SUT, ATC V01AA05 für die Zeit 01.11.2025 - 31.10.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Formoterol, Beclometason, Glycopyrronium, f. d. Z. 01.11.25 - 31.10.26 (zzgl. Verlängerungsoption 1x12 Mon)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glycopyrroniumbromid, ATC R03BB06 für die Zeit 01.11.2025 - 31.10.2026 (zzgl. Verlängerungsoption 1x12 Mon)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Lenograstim, ATC L03AA10 für die Zeit 01.11.2025 - 31.10.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Natriumphenylbutyrat, ATC A16AX03 für die Zeit 01.11.2025 - 31.10.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Filgotinib, ATC L04AF04 für die Zeit 01.11.2025 - 31.10.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Follitropin beta, ATC G03GA06 für die Zeit 01.11.2025 - 31.10.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clobetasol ausschließlich in der Darreichungsform Schaum, ATC D07AD01 für die Zeit 01.11.2025 - 31.10.2027
Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-09
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-09
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens
ted.europa.eu
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Lithuania – Crossheads – 31616 Geležinkelio iešmai
ted.europa.eu
Buyer: LTG Kompetencijų centras UAB (PV) | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-09-05
TenderProcurement ContractLithuaniaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: LTG Kompetencijų centras UAB (PV) | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-09-05
No saved opportunities on this page
Use the star icon near an opportunity title to add it to Favorites.
📅 Best viewed on desktop - or rotate your phone to landscape mode.
#
Opportunity
Type
Region / Country
Amount
Deadline
Source
41451
New approaches for Human/AI collaboration for the workforce of the future (RIA) (Made in Europe and AI, Data and Robotics partnerships)Expected Outcome:Industrial jobs are transformed through AI-based human-machine interactions (and skills linked to them) which enh...
Research Funding
Cash Grant
Europe
Expected EU contribution: 4,000,000 EUR - 6,000,000 EUR
Expected Outcome:Industrial jobs are transformed through AI-based human-machine interactions (and skills linked to them) which enhance flexibility, inclusion, well-being, up-skilling, career evolution and knowledge sharing;Increased competitiveness and sustainability of advanced manufacturing industries by means of knowledge formalization and adaptability of the machines to workers and markets based on different cultures. Scope:Innovative AI approaches are poised to revolutionise human-machine collaboration in factories by fostering an environment where technology and human expertise synergistically enhance each other. AI can enhance the value of the companies by capturing and formalising the knowledge which is dispersed and not explicit. This allows companies to really own the knowledge and use it to reduce the onboarding time of new employees and support personnel upskilling to adapt t...
41452
Efficient energy input from renewable sources and energy management in the process industries (IA) (Processes4Planet and Innovative Advanced Materials for the EU partnerships)Expected Outcome:A significant decarbonisation of processes (measured by the reduction of GHG emissions from the overall system) w...
Research Funding
Cash Grant
Europe
Expected EU contribution: 7,000,000 EUR - 9,000,000 EUR
Expected Outcome:A significant decarbonisation of processes (measured by the reduction of GHG emissions from the overall system) with broad applicability and economic viability.Facilitation of the transition from fossil-based energy inputs for: low/medium thermal energy demands by introducing renewable-based alternatives and heat upgrading. High-temperature processes, by innovative technologies for electrified and hybrid high-temperature processes, high temperature energy storage. Clean energy usage is given a boost through innovative advanced materials, system concepts and technologies for energy integration and energy storage, supporting resilience against energy supply variationsCombination of significant energy savings and integrated management of energy systems and production processes Scope:Most processes in the process industries require significant energy inputs which currently l...
41453
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tiotropiumbromid, in der Darreichungsform Inhalationslösung (Respimat(R)), ATC R03BB04Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-03
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-VerfahrensBuyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
41461
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tiotropiumbromid ausschließlich in der Dafo Lösung zur Inhalation, ATC R03BB04 f. d. Z. 01.11.25 - 31.10.27Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clobetasol ausschließlich in der Darreichungsform Schaum, ATC D07AD01 für die Zeit 01.11.2025 - 31.10.2027Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
41474
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-VerfahrensBuyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
